Final Adjusted Model* for the Association between polymerase chain reaction (PCR) Guided Care and Guideline Consistent Care
| Sign/Symptom | Estimate (β coefficient) | aOR (95% CI) |
|---|---|---|
| PCR guided care | 0.22 | 1.24 (0.83–1.88) |
| Tonsillar exudate | −1.76 | 0.17 (0.07–0.39) |
| Clinic 2 | −0.28 | 0.76 (0.48–1.18) |
| Clinic 3 | 0.58 | 1.79 (1.09–2.93) |
| Myalgia | 0.85 | 2.35 (1.61–3.42) |
| Pharynx erythema | −0.60 | 0.55 (0.37–0.82) |
| Pharynx exudate | −1.25 | 0.29 (0.13–0.63) |
| Rales | −0.98 | 0.38 (0.17–0.81) |
| Enlarged tonsils | −0.80 | 0.45 (0.26–0.78) |
| Duration of symptoms (≤2 days Vs >2 days) | 0.55 | 1.74 (1.17–2.57) |
| Unclear lungs | −0.78 | 0.46 (0.26–0.82) |
| Intercept | 1.49 | ——————— |
↵* H-L χ2 statistic, 10.9; P = .21; AUROCC, 0.77.
aOR, adjusted odds ratio; CI, confidential interval; PCR, polymerase chain reaction.